Assignee
DAIICHI SANKYO CO LTD
JP·302 granted patents·233 pending applications·1,435 citations·filing 2001–2025
Top patents by PatentIndex Score
535 records- 0198US7314923B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2003·Granted Jan 1, 2008·214 cites·12 claims
- 0297US10729782B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2017·Granted Aug 4, 2020·18 cites·13 claims
- 0397US9808537B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 7, 2017·44 cites·18 claims
- 0497US9657050B2ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursorsDAIICHI SANKYO CO LTD·Filed 2015·Granted May 23, 2017·31 cites·18 claims
- 0597US7335765B2Nucleoside and oligonucleotide analoguesDAIICHI SANKYO CO LTD·Filed 2001·Granted Feb 26, 2008·174 cites·60 claims
- 0696US11472784B2Griseofulvin compoundDAIICHI SANKYO CO LTD·Filed 2021·Granted Oct 18, 2022·4 cites·13 claims
- 0796US10973924B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 13, 2021·9 cites·2 claims
- 0896US10975052B2Griseofulvin compoundDAIICHI SANKYO CO LTD·Filed 2020·Granted Apr 13, 2021·5 cites·10 claims
- 0996US10906974B2Anti-GPR20 antibody and anti-GPR20 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 2, 2021·9 cites·30 claims
- 1096US10195288B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 5, 2019·43 cites·35 claims
- 1196US9850312B2Anti-TROP2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 26, 2017·64 cites·14 claims
- 1296US7816333B2Oligonucleotide analogues and methods utilizing the sameDAIICHI SANKYO CO LTD·Filed 2007·Granted Oct 19, 2010·43 cites·19 claims
- 1395US10227417B2Anti-TROP2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2017·Granted Mar 12, 2019·27 cites·16 claims
- 1495US10155821B2Anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 18, 2018·17 cites·8 claims
- 1595US9872924B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2013·Granted Jan 23, 2018·36 cites·47 claims
- 1694US9540386B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2016·Granted Jan 10, 2017·9 cites·3 claims
- 1794US7923573B2Benzene compound having 2 or more substituentsDAIICHI SANKYO CO LTD·Filed 2005·Granted Apr 12, 2011·90 cites·75 claims
- 1893US11795236B2Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Oct 24, 2023·6 cites·12 claims
- 1993US11584800B2Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 21, 2023·2 cites·7 claims
- 2093US9803199B2Cationic lipidDAIICHI SANKYO CO LTD·Filed 2014·Granted Oct 31, 2017·31 cites·29 claims
- 2193US9359368B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2013·Granted Jun 7, 2016·10 cites·4 claims
- 2292US11872289B2Anti-MUC1 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2022·Granted Jan 16, 2024·4 cites·22 claims
- 2392US10654821B2Griseofulvin compoundDAIICHI SANKYO CO LTD·Filed 2019·Granted May 19, 2020·5 cites·9 claims
- 2492US9745315B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2016·Granted Aug 29, 2017·5 cites·3 claims
- 2592US9718830B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2016·Granted Aug 1, 2017·5 cites·3 claims
- 2692US9718831B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2016·Granted Aug 1, 2017·5 cites·3 claims
- 2792US9187489B2Imidazo[1,2-b]pyridazine derivatives as kinase inhibitorsDAIICHI SANKYO CO LTD·Filed 2013·Granted Nov 17, 2015·45 cites·35 claims
- 2891US8357808B2Process for producing diamine derivativeDAIICHI SANKYO CO LTD·Filed 2011·Granted Jan 22, 2013·9 cites·18 claims
- 2990US12246196B2Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepinesDAIICHI SANKYO CO LTD·Filed 2022·Granted Mar 11, 2025·1 cites·34 claims
- 3090US11407746B2Griseofulvin compound and pharmaceutical use thereofDAIICHI SANKYO CO LTD·Filed 2018·Granted Aug 9, 2022·5 cites·20 claims
- 3190US10383878B2Anti-HER3 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Aug 20, 2019·29 cites·17 claims
- 3290US8785438B2Imidazopyridin-2-one derivativesDAIICHI SANKYO CO LTD·Filed 2013·Granted Jul 22, 2014·22 cites·45 claims
- 3390US7892835B2Pluripotent stem cell growing methodDAIICHI SANKYO CO LTD·Filed 2005·Granted Feb 22, 2011·19 cites·13 claims
- 3490US7365205B2Diamine derivativesDAIICHI SANKYO CO LTD·Filed 2002·Granted Apr 29, 2008·30 cites·6 claims
- 3589US12060365B2Cycloalkane-1,3-diamine derivativeDAIICHI SANKYO CO LTD·Filed 2021·Granted Aug 13, 2024·2 cites·20 claims
- 3689US11583590B2Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumorDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 21, 2023·1 cites·30 claims
- 3789US11292828B2KLK5 inhibitory peptideDAIICHI SANKYO CO LTD·Filed 2021·Granted Apr 5, 2022·2 cites·29 claims
- 3889US11077202B2Anti-CDH6 antibody and anti-CDH6 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Aug 3, 2021·2 cites·30 claims
- 3989US2025049782A1Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 4088US10570109B2Griseofulvin compoundDAIICHI SANKYO CO LTD·Filed 2017·Granted Feb 25, 2020·5 cites·14 claims
- 4188US9884871B2Crystals of dispiropyrrolidine derivativesDAIICHI SANKYO CO LTD·Filed 2016·Granted Feb 6, 2018·5 cites·3 claims
- 4288US8889741B2Cycloalkane derivativesDAIICHI SANKYO CO LTD·Filed 2013·Granted Nov 18, 2014·28 cites·26 claims
- 4388US7449185B2Antibodies to OCIF-binding moleculesDAIICHI SANKYO CO LTD·Filed 2004·Granted Nov 11, 2008·19 cites·57 claims
- 4487US12186310B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·1 claims
- 4587US11845786B2Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8DAIICHI SANKYO CO LTD·Filed 2021·Granted Dec 19, 2023·1 cites·23 claims
- 4687US11236106B2Cycloalkane-1,3-diamine derivativeDAIICHI SANKYO CO LTD·Filed 2021·Granted Feb 1, 2022·2 cites·17 claims
- 4787US11091560B2Anti-human TLR7 antibodyDAIICHI SANKYO CO LTD·Filed 2020·Granted Aug 17, 2021·2 cites·28 claims
- 4887US10550154B2Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 4, 2020·5 cites·12 claims
- 4987US2025059151A1Griseofulvin compoundDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 5087US2025042947A1Peptide library and use thereofDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
Showing the top 50 of 535 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DAIICHI SANKYO CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →